Russia prepares for shortage of anti-cancer drugs – The Pharma Letter

07-04-2022 Comments (0)Print
30-03-2022
21-03-2022
03-06-2019
14-06-2018
28-03-2022
19-03-2022
15-03-2022
Russia prepares for shortage of anti-cancer drugs

The Russian Ministry of Health has prepared a list of 39 anticancer drugs that are likely to be in short supply in the country due to ongoing military conflict between Ukraine and Russia and Western sanctions imposed on Russia, reports The Pharma Letter’s local correspondent.
Most of drugs included in the list are used to treat the most common types of cancer: melanoma, breast cancer, bronchial, lung and prostate cancer and are original drugs,…


This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
 
• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
• Receive The Pharma Letter daily news bulletin, free forever.

• Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
• Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
• Daily roundup of key events in pharma and biotech.
• Monthly in-depth briefings on Boardroom appointments and M&A news.
• Choose from a cost-effective annual package or a flexible monthly subscription.
Focus OnFrom our correspondentIn DepthOncologyPharmaceuticalPricing, reimbursement and accessProductionPublic healthRussiaRussian market
The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.
The Pharma Letter
39 to 43 Putney High Street
Putney
London
SW15 1SP
For trial and subscription enquiries please email subscriptio[email protected]
For editorial enquiries, press releases and events please email [email protected]
For all other queries please email [email protected]
Agile web development by Byte9
Back to top

source

Add a Comment

Your email address will not be published. Required fields are marked *